Takara Bio Inc. (TYO:4974)

Takara Bio Revenue

In the fiscal year ending March 31, 2026, Takara Bio had annual revenue of 40.32B JPY, down -10.48%. Takara Bio had revenue of 11.93B in the quarter ending March 31, 2026, a decrease of -24.31%.

• Revenue: 40.32B
• Revenue Growth: -10.48%
• P/S Ratio: 3.41
• Revenue / Employee: 22.66M
• Employees: 1,779
• Market Cap: 137.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	40.32B	-4.72B	-10.48%
Mar 31, 2025	45.04B	1.53B	3.53%
Mar 31, 2024	43.51B	-34.64B	-44.33%
Mar 31, 2023	78.14B	10.44B	15.43%
Mar 31, 2022	67.70B	21.61B	46.90%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error